Profit & Loss

Zydus Lifesciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	532321	NSE Symbol:	ZYDUSLIFE	P/E :	34.04
ISIN Demat:	INE010B01027	Div & Yield %:	0.08	EPS :	36.54
Book Value:	237.30	Market Cap (Rs. Cr.):	124,089.48	Face Value :	1

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
INCOME :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Sales Turnover	11,486.40	15,117.80	10,817.70	8,732.60	7,835.00	7,780.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	11,486.40	15,117.80	10,817.70	8,732.60	7,835.00	7,780.00
Other Income	1,667.50	696.20	1,084.80	548.40	178.70	89.30
Stock Adjustments	151.60	121.10	131.70	-105.10	46.90	148.30
Total Income	13,305.50	15,935.10	12,034.20	9,175.90	8,060.60	8,017.60
EXPENDITURE :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Raw Materials	3,728.40	3,138.00	3,284.60	3,066.20	2,917.10	2,499.70
Power & Fuel Cost	305.60	286.20	298.20	278.60	245.20	193.20
Employee Cost	1,966.20	1,762.20	1,507.50	1,321.90	1,204.90	1,147.30
Other Manufacturing Expenses	486.70	439.70	347.20	332.50	381.10	363.40
Selling & Administrative Expenses	1,805.40	1,629.30	1,016.80	1,040.80	956.50	1,009.10
Miscellaneous Expenses	-412.80	247.20	445.00	336.90	578.30	594.40
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	7,879.50	7,502.60	6,899.30	6,376.90	6,283.10	5,807.10
Operating Profit	5,426.00	8,432.50	5,134.90	2,799.00	1,777.50	2,210.50
Interest	482.90	463.90	390.70	278.20	134.90	70.90
Gross Profit	4,943.10	7,968.60	4,744.20	2,520.80	1,642.60	2,139.60
Depreciation	561.20	523.90	504.40	488.60	478.70	451.10
Profit Before Tax	4,381.90	7,444.70	4,239.80	2,032.20	1,163.90	1,688.50
Tax	899.80	1,582.50	934.30	461.80	260.20	303.30
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-77.70	87.30	-136.00	41.20	45.80	-91.00
Reported Net Profit	3,559.80	5,774.90	3,441.50	1,529.20	857.90	1,476.20
Extraordinary Items	-131.38	42.40	6.10	-92.27	-237.64	-156.95
Adjusted Net Profit	3,691.18	5,732.50	3,435.40	1,621.47	1,095.54	1,633.15
Adjustment below Net Profit	-10.10	-26.40	-54.00	1.80	-6.90	-15.30
P & L Balance brought forward	18,794.20	13,347.60	10,567.40	9,289.40	8,796.90	7,336.00
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1,106.90	301.90	607.30	253.00	358.50	0.00
P & L Balance carried down	21,237.00	18,794.20	13,347.60	10,567.40	9,289.40	8,796.90
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	100.00	1,100.00	300.00	600.00	250.00	350.00
Dividend Per Share(Rs)	1.00	11.00	3.00	6.00	2.50	3.50
Earnings Per Share-Unit Curr	35.39	57.40	34.21	15.11	8.38	14.42
Earnings Per Share(Adj)-Unit Curr	35.39	57.40	34.21	15.11	8.38	14.42
Book Value-Unit Curr	235.31	210.64	156.23	134.78	129.30	124.46
Book Value(Adj)-Unit Curr	235.31	210.64	156.23	134.78	129.30	124.46

Company Snapshot

Read it, Learn it and Do it for your investment Needs

Profit & Loss